Business

In a bold move, Novo Nordisk has introduced a transformative pricing model for its weight loss drug Wegovy, slashing the cost to $499 per month through its direct-to-consumer platform, NovoCare. This significant reduction—over 60% from the original list price—has the potential to reshape the healthcare landscape for those struggling with obesity. It is a welcome

Target has been synonymous with accessible, trendy merchandise for years, yet it now finds itself teetering on the brink of a significant crisis in the discretionary retail space. As it prepares for its fiscal fourth-quarter earnings report, analysts are speculating about how well the retailer can navigate the murky waters of today’s economic climate. A

For decades, stuffed crust pizza has been a staple in the minds and stomachs of Americans, thanks largely to Pizza Hut’s bold introduction of the concept back in the early ’90s. This feature was so iconic that it starred in a commercial with none other than Donald Trump, who has since become a figure synonymous

In recent years, the aviation industry has witnessed a remarkable evolution in passenger comfort, particularly in first and business class. Amenities such as heated and cooled seats, ultra-high-definition entertainment systems, and spacious designs have become the gold standard for airlines eager to attract high-paying customers. Yet, the quest for luxury is proving to be a

American Airlines is embarking on an ambitious initiative to test complimentary inflight Wi-Fi, commencing next week. This trial comes amid increasing pressure from both consumers and competitors to provide free internet access during flights. Unlike the traditional model that often involved substantial fees—sometimes exceeding $20 for a single flight—American’s trial flights will serve as a

The recent confirmation hearing for Jonathan McKernan, President Donald Trump’s nominee to head the Consumer Financial Protection Bureau (CFPB), has spotlighted the tense political landscape surrounding the agency. Democrats, particularly Senator Elizabeth Warren, rigorously questioned McKernan on his commitment to uphold the legal responsibilities of the CFPB in light of the substantial cuts and administrative

Eli Lilly, a prominent player in the pharmaceutical industry, announced a significant commitment of at least $27 billion towards constructing four new manufacturing sites across the United States. This decision comes amid a surge in demand for their leading obesity and diabetes medications, including tirzepatide, a crucial element in their market-leading products. The company’s latest

In a moment that signifies both a transition and a testament to the evolving landscape of the electric vehicle (EV) market, Lucid Group has announced the departure of its CEO Peter Rawlinson. As the company braces itself for an ambitious target to more than double production this year to reach 20,000 vehicles, leadership dynamics are

In a recent interview, Jamie Dimon, the CEO of JPMorgan Chase, offered a candid assessment of the U.S. government’s operational efficacy. His commentary highlights a broader discussion regarding governmental efficiency, underlining that the system is beset by inefficiencies and a lack of competence. Dimon didn’t pull punches when he characterized various government agencies as failing

Bluebird Bio’s recent decision to sell itself to Carlyle and SK Capital for approximately $30 million may be viewed as the final chapter in a tumultuous narrative that chronicles the rise and fall of one of the biotech sector’s once-promising contenders. This strategic maneuver signals not only the end of an era for Bluebird but